Skip to content
PICO Portalanswers from OpenAlex

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma

PaperCitations, authors & open-access status

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is a paper indexed in PICO Portal from OpenAlex.

How many citations does Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma have?

PICO Portalcitation count

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma has 51 citations in the OpenAlex counts PICO Portal stores.

When was Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma published?

PICO Portalyear

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma has 2020 year in the PICO Portal index.

What is the open-access status of Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?

PICO Portaloa status

Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma has closed oa status in the PICO Portal index.

What is the DOI of Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?

PICO Portaldoi

The DOI for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is on the source record.

What is the PMID of Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?

PICO Portalpmid

The PMID for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is on the source record.

What is the OpenAlex record for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma?

PICO Portalopenalex

The OpenAlex for Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial